Xin Zhai

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Inflammatory Response

Epidermal Growth Factor Receptor

Top Venues

Archiv der Pharmazie

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Jiahao Zhang, Shuming Xing, Jianming Cui, Xiujian Wei, Zhi Cao, Bin Shao, Nan Jiang, Xin Zhai
Structure-guided design of potent JAK1-selective inhibitors based on 4-amino-7H-pyrrolo[2,3-d]pyrimidine with anti-inflammatory efficacy. Archiv der Pharmazie (2024)
Jiahao Zhang, Shuming Xing, Jianming Cui, Xiujian Wei, Zhi Cao, Bin Shao, Nan Jiang, Xin Zhai
Structure-guided design of potent JAK1-selective inhibitors based on 4-amino-7H-pyrrolo[2,3-d]pyrimidine with anti-inflammatory efficacy. Archiv der Pharmazie 357 (4) (2024)
Zehui Tan, Ning Guo, Shuyu Liu, Jiandong Li, Yu Chen, Jianming Cui, Hongrui Lei, Nan Jiang, Lihui Wang, Xin Zhai
Discovery of Novel Non-nucleoside DOT1L R231Q Inhibitors with Improved Pharmacokinetic Properties and Anti-lung Cancer Efficacy. Journal of medicinal chemistry (2024)
Jiahao Zhang, Shuming Xing, Jianming Cui, Xiujian Wei, Zhi Cao, Bin Shao, Nan Jiang, Xin Zhai
Structure-guided design of potent JAK1-selective inhibitors based on 4-amino-7H-pyrrolo[2,3-d]pyrimidine with anti-inflammatory efficacy. Archiv der Pharmazie 357 (4) (2024)
Jiahao Zhang, Shuming Xing, Jianming Cui, Xiujian Wei, Zhi Cao, Bin Shao, Nan Jiang, Xin Zhai
Structure-guided design of potent JAK1-selective inhibitors based on 4-amino-7H-pyrrolo[2,3-d]pyrimidine with anti-inflammatory efficacy. Archiv der Pharmazie 357 (4) (2024)
Shuyu Liu, Fuyi Wang, Juanjuan Yang, Guangyue Su, Zhi Cao, Mengya Shan, Xin Zhai
Identification of highly potent 2,4-diarylaminopyrimidine analogs of a typical piperidinyl-4-ol moiety as promising antitumor ALK inhibitors. Archiv der Pharmazie (2023)
Tong Li, Hongrui Lei, Juanjuan Yang, Zhi Cao, Yu Yang, Zimeng Liu, Ruonan Sun, Xinlian Yang, Xin Zhai
Hybrid imidazo[1,2-a]pyridine analogs as potent ATX inhibitors with concrete in vivo antifibrosis effect. Archiv der Pharmazie 355 (10) (2022)
Hongrui Lei, Ming Guo, Xiaopeng Li, Fang Jia, Changtao Li, Yu Yang, Meng Cao, Nan Jiang, Enlong Ma, Xin Zhai
Discovery of Novel Indole-Based Allosteric Highly Potent ATX Inhibitors with Great In Vivo Efficacy in a Mouse Lung Fibrosis Model. Journal of medicinal chemistry 63 (13) (2020)